Filter News
Area of Research
- (-) Nuclear Science and Technology (6)
- (-) Supercomputing (10)
- Advanced Manufacturing (1)
- Biological Systems (1)
- Biology and Environment (1)
- Clean Energy (12)
- Climate and Environmental Systems (1)
- Computational Biology (1)
- Energy Frontier Research Centers (1)
- Fuel Cycle Science and Technology (1)
- Materials (20)
- Neutron Science (11)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Sensors and Controls (1)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
Seven researchers from the Department of Energy’s Oak Ridge National Laboratory have been chosen by the Innovative and Novel Computational Impact on Theory and Experiment, also known as INCITE, program to lead scientific investigations that require the nation’s mo...
The United Kingdom’s National Nuclear Laboratory and the U.S. Department of Energy’s Oak Ridge National Laboratory have agreed to cooperate on a wide range of nuclear energy research and development efforts that leverage both organizations’ unique expertise and capabilities.
The US Department of Energy’s Oak Ridge National Laboratory is once again officially home to the fastest supercomputer in the world, according to the TOP500 List, a semiannual ranking of the world’s fastest computing systems.
In an effort to reduce errors in the analyses of diagnostic images by health professionals, a team of researchers from the Department of Energy’s Oak Ridge National Laboratory has improved understanding of the cognitive processes
The U.S. Department of Energy’s Oak Ridge National Laboratory today unveiled Summit as the world’s most powerful and smartest scientific supercomputer.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.